Study Design. Investigation of the effects of prostaglandin E1, melatonin, and oxytetracycline on lipid peroxidation, antioxidant and paraoxonase activities, and homocysteine levels in an experimental model of spinal cord injury.
These alterations were relatively suppressed by prostaglandin E1, melatonin, and oxytetracycline administrations in varying degrees. Melatonin was the most powerful agent, particularly at the fourth hour. Oxytetracycline was also effective, both at the first and fourth hour. Prostaglandin E1 was effective in comparison to injury group, but not as much as melatonin and oxytetracycline.
Conclusions. Melatonin and oxytetracycline are effective in preventing lipid peroxidation in spinal cord injury. Paraoxonase and homocysteine can be used in monitoring the antioxidant defense system as well as superoxide dismutase and plasma glutathione peroxidase, both in injury and medicated groups. Hypoxic and traumatic injuries to the spinal cord lead to the earliest biochemical reactions such as hydrolysis of fatty acids from membrane phospholipids, production of biologically active eicosanoids, and peroxidation of lipids with the formation of reactive oxygen species (ROS). The spinal cord is particularly vulnerable to free radical oxidation because of the high lipid content 1 and poor iron-binding capacity. Superoxide (O 2 Ϫ ), ferryl, and hydroxyl anions are the common ROS and main agents responsible for cellular damage and lipid peroxidation. 2, 3 Under normal conditions, there is a balance between antioxidants and oxidants produced by aerobic cellular systems. One of the antioxidant systems is superoxide dismutase (SOD), which eliminates superoxides by converting them to hydrogen peroxide (H 2 O 2 ). 4 ,5 H 2 O 2 is reduced to water by cytosolic antioxidants, catalase, and glutathione peroxidase (GSH-Px). 6 -8 Oxidative stress and ROS initiate lipid peroxidation not only in cell membranes but also in circulating lipoproteins where oxidative stress is prolonged, 9 leading to an increase in plasma conjugated dienes, lipid hydroperoxides, and thiobarbituric acid reactive (TBAR) substances. 10 Paraoxonase (PON1) is a calciumdependent 11 antioxidant enzyme that circulates on highdensity lipoproteins (HDLs) and contains apoA1 and clusterin. 12, 13 The paraoxonase gene family contains three members, and the PON1 gene product is serum PON, which is expressed mainly in the liver and normally hydrolyzes organophosphates.
14 On the other hand, hyperhomocystinemia-a reflection of intracellu-lar homocysteine formation-may also represent an oxidative stress through auto-oxidation with the associated generation of hydrogen peroxide, homocystinyl radicals, and other ROS. 15, 16 In different studies, low PON1 levels and activities or hyperhomocystinemia have been found to be associated with chronic diseases in which prolonged oxidative stress underlies the pathology itself. There has been no study investigating their combined Figure 1 . Basal (G1) and firstand fourth-hour tissue MDA levels for each study group (G2-G5) represented by box plot graphic. MDA levels are increased in injury group G2, whereas the increase was suppressed by G4, relatively by G3, and least by G5.
responses in collaboration with the antioxidant defense system, particularly in the acute phase of the process, as well as under the influence of some medications. Many treatment regimens have come into use in time with the development of experimental spinal cord injury models and recent advances in spinal cord injury research. 4, [17] [18] [19] [20] [21] [22] [23] [24] Prostaglandin E1, [25] [26] [27] [28] [29] [30] [31] melatonin, 19, [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] and tetracycline derivates 46 -53 have been evaluated in separate studies and found useful. In this study, we aimed to investigate the responses of acute phase antioxidant defense systems in collaboration with the PON1 activities and the related homocysteine levels, either with or without medication, by measuring the extent of lipid peroxidation together with the alterations in this antioxidant enzymatic defense.
Material and Methods
Sixty-three male albino Wistar rats were included in the prospective randomized double-blinded study program. The rats weighing from 250 to 340 g were handled according to Principles of Laboratory Animal Care. 54 They were housed in cages under diurnal lighting conditions (12 hours darkness and 12 hours light), fed by pellets, and fasted overnight but allowed free access to water before the experiment. They were anesthetized by 400 mg/kg chloral hydrate and monitored in terms of blood pressure, heart rate, and body temperature during the study. The rats were divided into 5 groups; G1 was the control group (n ϭ 7), and laminectomy, injury, and administration of medication were not performed. It constituted the basal levels for the 1-and 4-hour marks of the study groups. G2 (n ϭ 14) was the only laminectomy and injury group. No medication was applied. The G3-G5 (each n ϭ 14) study groups received medications right after the clip application as prostaglandin E1 (Prostavasin®, 100 g amp; Schwarz-Pharma, Mainheim, Germany; 75 g/kg IM), melatonin (Melatonin®, 1g flacon; N-acetyl-5-methoxytryptamine; Sigma Chemicals Co.; 10 mg/kg IP), oxytetracycline (Primamycin/LA®; Pfizer, Istanbul, Turkey; 10 mg/kg IP), respectively.
In all animals in groups 2 through 5, the spinal cords were exposed with T3-T6 total laminectomies. Spinal cord injuries (G2-G5) as described by Rivlin and Tator 55 were accomplished by extradural compression of the exposed spinal cords at the T4 -T5 level for 30 seconds using a Yaşargil aneurysmal clips (FE 760) with a closing force of 180 g on the cord. Except in G1 and G2, medications were performed at the time of injury. Spinal cords were provided immediately in Group 1 and after removal of the clip, at the first and fourth hours in G2-G5 after killing the animals by decapitation. The cord samples were provided in 1 cm lengths at the lesion level and stored at Ϫ20 C for assays for tissue malonyldialdehyde (MDA). Simultaneously, 3 mL blood samples were drawn into tubes containing ethylenediaminetetraacetic acid (EDTA). The blood samples were processed, and plasma and serum samples were separated and assayed immediately.
Measurement of Tissue MDA Levels. Lipid peroxidation
in the injured spinal cord was estimated by the thiobarbituric acid reaction method for MDA (MDA defined as the product of lipid peroxidation) described by Ohkawa et al 56 to give a red species absorbing at 535 nm. The MDA results were expressed as nmol/g wet tissue.
The 0.2 mL of 10% (weight/volume) tissue homogenate was added to 0.2 mL of 8.1% sodium dodecyl sulfate and a 1:5 aqueous solution of thiobarbituric acid. The mixture was diluted to 4.0 mL with distilled water heated in an oil bath at 95 C for 60 minutes. After cooling with tap water, 1.0 mL of distilled water and 5.0 mL of a mixture of N-butanol and pyridine (15:1 volume:volume) were added, and the mixture was shaken. After centrifugation at 4000 rpm for 10 minutes, the organic layer was taken and its absorbance at 532 nm was measured spectrophotometrically. Tetramethoxy propane was measured as an external standard, and the level of lipid peroxides was expressed as nanomoles of MDA per gram wet weight.
Measurement of Blood MDA levels (MDA b ). Serum lipid peroxide levels were measured colorimetrically by the thiobarbituric acid method, which was modified from the methods of Satoh 57 and Yagi 58 as reported recently. The MDA levels were expressed as nanomoles per milliliter.
Measurement of Erythrocyte SOD levels. The role of SOD
is to accelerate the dismutation of the toxic superoxide radical (0 2 Ϫ ) produced during oxidative energy processes to hydrogen peroxide and molecular oxygen. This method employs xanthine and xanthine oxidase to generate superoxide radicals, which react with 2-(4-iodophenyl)-3-(4-nitrophenol)-5-phenyltetrazolium chloride to form a red formazan dye. The SOD activity is then measured by the degree of inhibition of this reaction. This was accomplished with a RANSOD kit (Randox, Crumlin, United Kingdom). Levels of hemoglobin were measured according to the method of Drabkin. 59 Results were expressed as units per gram of hemoglobin.
Measurement of Erythrocyte GSH-Px Activity Levels.
Glutathione peroxidase activity levels were measured using a RANSEL kit (Randox) using the method of Paglia and Valentine, 60 in which GSH-Px activity is coupled with the oxidation of NADPH by glutathione reductase. The oxidation of NADPH was followed spectrophotometrically at 340 nm and at 37 C. The reaction mixture consisted of 50 mmol/L potassium phosphate buffer (pH 7), 1 mmol/L EDTA, 1 mmol/L NaN 3 , 0.2 mmol/L NADPH, 1 mmol/L glutathione, and 1 U/mL of glutathione reductase. The absorbance at 340 nm was recorded for 5 minutes. The activity was calculated from the slope of the lines as micromoles of NADPH oxidized per minute. Results were expressed as units/L.
Measurement of Serum Paraoxonase (PON1) Activities.
Paraoxonase activity was assayed either without any addition of NaCl (basal activity) or with the addition of 1 mol/L NaCl (salt-stimulated activity) and determined according to Eckerson et al. 61 One unit of paraoxonase activity was described as the amount of PON producing 1 micromol of p-nitrophenol per minute per liter of serum (mol/min/L).
Measurement of Homocysteine (Hcy) Levels. Plasma Hcy levels were measured by Axis Homocysteine EIA kits with Biotec-Elx-800 in mol/L. Axis Homocysteine is an enzyme immunoassay for the determination of total Hcy in blood. 62 Protein-bound homocysteine is reduced to free homocysteine and enzymatically converted to S-adenosyl-L-homocysteine in a separate procedure before the immunoassay. 52 The enzyme is specific for the L-form of homocysteine, which is the only form present in the blood. . Basal (G1) and firstand fourth-hour erythrocyte SOD levels for each study group (G2-G5) represented by box plot graphic. SOD levels are decreased in injury group G2, whereas the decrease is suppressed by G4, relatively by G3, and least by G5. ϩ ϭ P Ͻ 0.03, Wilcoxon Rank test.
Statistical Analysis. SPSS 9.0 software was used in statistical calculations and graphics. For intergroup comparison, the Kruskal-Wallis variance analysis was applied for 5 independent groups, each consisting of Յ30 subjects. In case the P value was Ͻ0.05, the groups were compared two by two by Bonferroni corrected Mann-Whitney U test (MWU). P Ͻ 0.025 was accepted as significant. For intragroup comparison, because the number of comparisons was 3 and n Ͻ 30 in each group, Friedman variance analysis was applied, and those with P value Ͻ 0.05 were compared two by two by Wilcoxon rank test (WRT) and P Ͻ 0.03 was accepted as significant.
Results
Results of each group were expressed as mean Ϯ standard deviation of the mean (Table 1) .
Statistically, intergroup comparison was done. In G1-G2, G1-G3, G2-G3, G2-G4, and G2-G5 comparisons, groups differed from each other for all parameters (P Ͻ 0.025, MWU). However, G1-G5 also differed from each other for all parameters (P Ͻ 0.025) except for the fourth hour MDA (P ϭ 0.06) and SOD (P ϭ 0.05) levels. G1-G4 was different for all first hour parameters (P Ͻ 0.025) except for Hcy (P ϭ 0.03), but similar for the fourth hour except for SOD (P ϭ 0.002) levels. For G3-G4 and G3-G5, they were all similar for first hour (P Ͼ0.025) except for G3-G4 SOD (P ϭ 0.002) values, and they were different for fourth hour except for G3-G5 PON1 (P ϭ 0.06) values. For G4 -G5, first-hour levels were all similar (P Ͼ 0.025) except for SOD (P ϭ 0.002) value. Fourth-hour levels were different for MDA b , PON1, and SOD (P Ͻ 0.02), but similar for MDA (P ϭ 0.1), GSH-Px (P ϭ 0.03), and Hcy (P ϭ 0.5).
For intragroup comparison, all parameters at 0 minutes, the first hour, and the fourth hour differed from each other (P Ͻ 0.03, WRT) except for fourth hour PON1 and GSH-Px in Group 4, which were similar to the basal correspondent levels (P ϭ 0.06, P ϭ 0.4, respectively) (Figures 1-6 ).
According to the statistical analysis given above, laminectomy was not found statistically different from the control group. Melatonin was most effective particularly in terms of fourth-hour parameters. Oxytetracycline was also effective at the fourth hour, but not as much as melatonin. Both were similarly efficacious at the first hour. PGE1 was effective particularly at the first hour when compared to the injury group, but not as much as the other two.
Discussion
Oxidative stress and ROS initiate lipid peroxidation in cell membranes and in circulating lipoproteins, 9 which results in increased plasma conjugated dienes, lipid hydroperoxides, and TBAR substances. 10 Oxidized LDL (Ox-LDL) may trigger platelet activation, 9,63 thrombin- . Basal (G1) and firstand fourth-hour erythrocyte GSH-Px activity levels for each study group (G2-G5) represented by box plot graphic. GSH-Px activity levels are decreased in injury group G2, whereas the decrease is suppressed by G4, relatively by G3, and least by G5. ϩ ϭ P Ͻ 0.03, Wilcoxon Rank test.
induced thromboxane synthesis, and tissue factor activity of macrophages 64 and cause cytotoxicity to cells in the arterial wall and other pathologies. Antioxidants can prevent the formation of Ox-LDL; when antioxidant protection is not sufficient, elimination of Ox-LDL from extracellular spaces, after it was formed under excessive oxidative stress, can possibly be achieved by the hydrolytic action of PON1 on lipoprotein's lipid peroxides. 65, 66 PON1 has known to be implicated in chronic cases, i.e., cardiovascular disease, 67, 68 hypertensive type II diabetes, 69 myocardial infarction, 68,70 chronic renal failure, 71 and cerebral small-vessel disease. 72 Newborns have very low levels of PON1, and adult levels in rats and mice are reached at 3 weeks of age and in humans sometimes after 6 months. 73 For optimal PON1 activity, coassembly of the enzyme onto nascent HDL is required and apo-A1 may be important in this assembly. 74 Dietary fat, 65, 75 or cysteine substitutions in apo-1, modulate PON1 activity. 74 Thiol compounds methionine and cysteine are the precursors of homocysteine (Hcy). 74, 76 However, hyperhomocysteinemia (HHcy) not resulting from natural processes [77] [78] [79] [80] [81] is a reflection of intracellular Hcy formation, which represents an oxidative stress through auto-oxidation, with the associated generation of hydrogen peroxide, homocysteinyl radicals, and other ROS. 15, 16 The thioester Hcy thiolactone-a metabolite of Hcy-damages proteins, which may underlie Hcyassociated diseases in humans. However, PON1 is Hcy thiolactonase, which counteracts the detrimental effects of Hcy. 67, 68 HHcy is known to cause endothelium dilatation [82] [83] [84] and to enhance activities of factor V, prothrombin, 85 and adhesiveness of the platelets 9,86 as well as the reactivity of the plasminogen-like apolipoprotein (a) and the affinity of lipoprotein (a) for fibrin. 87, 88 Like other physiologic thiol compounds, Hcy could mediate Cu-and Fe-dependent low-density lipoprotein (LDL) oxidation, 88 -90 affect the intracellular reduced glutathione level and leukotriene B4 production, 91 and induce neuronal apoptosis by stimulating NMDA receptors and hypersensitivity to excitotoxicity in vivo and in vitro [92] [93] [94] [95] ; thereby it has been implicated in similar pathologies as PON1, i.e., atherogenesis and cardiovascular diseases, 65, 90 rheumatoid arthritis, 91 thrombotic cerebrovascular disease, 96 and neurodegenerative diseases. 75, 94 Pathologies mentioned above are generally associated with low PON1 levels or activities, which suggest that PON1 is consumed excessively. Normal plasma levels in rats are found as 67 Ϯ 9 mol/min/L. 75 The decrease in serum concentration (decreased synthesis and/or enhanced catabolism) 70, 97 being relatively greater than the decrease in activity initially has suggested that the low concentration could be the primary factor in most pathologies. 70 However, there is a possibility that the event itself ultimately lowered PON1. 24, 70 PON1 activity and mRNA levels in liver decrease 24 hours after endotoxin administration and also TNF and IL-1, cytokines, which mediate the acute phase response. 13, 97 From this standpoint, it can be concluded that the plasma level reduc- Figure 5 . Basal (G1) and firstand fourth-hour PON1 activity levels for each study group (G2-G5) represented by box plot graphic. PON1 levels are increased in injury group G2, the increase is suppressed by G4, relatively by G3, and least by G5. ϩ ϭ P Ͻ 0.03, Wilcoxon Rank test.
tions likely take place relatively at a later stage. We did not monitor the responses after 24 hours and so on because TBAR substance content in the spinal cord was found to increase after injury with two peaks (at 1 and 4 hours), 35 and we designed our study accordingly. Because there is continuous interaction between pathology and the antioxidant enzymes from the beginning, increased levels of PON1 and activity can be expected to be protective in the early phase of the oxidative stress, at which PON1 has not been exhausted yet. In our study, all PON1 levels at the first and fourth hour of injury were found consistently increased in the injury group according to the baseline levels, and this difference was statistically significant. Surprisingly, an interaction and inverse correlation between PON1 activity and Hcy levels was also noted. This inverse relationship was probably due to the enzymatic linkage between PON1 and Hcy as described before. Normal plasma range of Hcy is 5-15 mol/L. 86 In previous studies, at normal plasma concentrations (6 mol/L) Hcy showed no effect. At 25 mol/L, Hcy stimulated lipid peroxidation of LDL. HHcy inhibited GSH-Px 98 and decreased the expression of GSHPx 99 and extracellular SOD. 100 Interestingly, concentrations of Ն50 M result in an adaptive increase in activity of antioxidant enzymes (GSH-Px and SOD) in the circulation, 64 ,101-103 thereby delaying the onset of oxidation. However, plasma GSH-Px and SOD are found in low concentrations compared with the erythrocyte and endothelial forms. 104 In our study, increased PON1 activities and decreased plasma Hcy levels in trauma were associated with the increased tissue and blood MDA levels and decreased erythrocyte SOD levels and GSH-Px activities. We concluded that PON1 and Hcy alterations were a protective response as a result of antioxidant enzyme consumption. We confirmed our hypothesis by administering some so-called antioxidant medications and monitored the responses again at the first and fourth hours. The response as increase in PON1 and decrease in Hcy was relatively suppressed by these different therapies at varying degrees, compared to injury. PGE1, melatonin, and oxytetracycline were ineffective in keeping the parameters close to basal levels except for melatonin in the fourth hour. However, melatonin was effective both at the first and fourth hour in respect to injury. Melatonin-a powerful antioxidant-has been demonstrated to scavenge hydroxyl and peroxyl radicals, 42, 44 being more effective than vitamin E, mannitol, glutathione, 42, 44 and methylprednisolone. 19 It decreased damage to DNA, 44 proteins, 32 and lipids 39 in vivo. Melatonin (12.5 mg/kg) reduced lipid peroxidation products and myeloperoxidase activity and facilitated recovery of the damaged spinal cord in rats 35 and protected against cellular damage.
105 It enhanced immune function by acting directly on immune cells in experi- Figure 6 . Basal (G1) and firstand fourth-hour homocysteine levels for each study group (G2-G5) represented by box plot graphic. Hcy levels are decreased in injury group G2, the decrease is suppressed by G4, relatively by G3, and least by G5. ϩ ϭ P Ͻ 0.03, Wilcoxon Rank test.
mental study. 38 Melatonin has also been proposed as a neuroprotective and antiapoptotic agent, as it readily penetrates the blood-brain barrier and diffuses into neurons and glia equally well. 41, 106, 107 It decreases excitotoxicity and traumatic brain injury 36, 40 and improves cerebral circulation security margins in rats. 43 It counteracts Hcy-induced vasoconstriction. 108 Pharmacological levels of melatonin have been reported to increase GSH-Px, glucose-6-phospate dehydrogenase, SOD, and catalase activity in the erythrocyte and their expressions and decrease oxidized glutathione activity. 33, 34, 37, 45 In our study, melatonin increased SOD levels and preserved GSH-Px activity close to basal levels. Effectiveness at the first hour did not differ from the other drugs, but at the fourth hour, it totally differed from PGE1 and partially from oxytetracycline.
Tetracycline is a readily available, inexpensive, and safe prophylactic therapeutic agent, provided it is not used in high doses (up to 0.5 g/kg), which increases peroxidation of lipid unsaturated fatty acids of the liver cell membrane itself. 51 Anti-inflammatory effects of tetracycline derivates 46 -48 are ranked as oxytetracycline Ͼ tetracycline Ͼ chlortetracycline Ͼ doxycycline.
2,64 Rabbits pretreated with doxycycline had reduced in vitro leukocyte adherence and significantly increased tolerance to temporary spinal cord ischemia. 46 Tetracycline delayed anti-inflammatory processes in middle cerebral artery occlusion. 49, 95 A dose of 10 mg/kg administered intravenously over 5 minutes had significantly decreased electrophysiological and neurologic abnormalities. 50 Minocycline, by inhibiting microglia, protects against NMDA neurotoxicity by inhibiting inflammatory processes, IL1beta converting enzymes, and iNOS synthase upregulation in animal models of ischemic stroke. 53 In our study, oxytetracycline was the second most potent drug, particularly at the fourth hour. It was relatively ineffective according to basal levels but effective in respect to injury both at first and forth hour. Effectiveness at the first hour did not differ from that of PGE1 and melatonin, but it was effective at the fourth hour compared to PGE1, but not as much as melatonin.
In our study, PGE1 was found effective particularly at the first hour in comparison to injury, despite being the least potent drug of all. Prostacyclin (PGE1/I 2 ) has been known to inhibit thromboplastin (monocyte tissue factor)/factor VIIa-dependent thrombin formation and platelet procoagulant activity 26, 29 through a cAMPindependent and a cAMP-dependent pathway. 25 However, in spinal cord injury (SCI), the inhibitory effect of prostacyclin on thrombin generation is lost, probably due to the loss of platelet high-affinity prostanoid receptors, which may contribute to vascular damage in individuals with SCI. 109 Nevertheless, the neuroprotective effect maybe due to its ability of scavenging free radicals. 30 PGE1 and SOD together prevented ischemic spinal cord injury by intravenous 100 ng/kg/min. 27 Anterior spinal cord blood flow is maintained despite vasodilatation hypotension by PGE1 31 ; however, a small dose of 12.5 ng/kg/min may prevent this complication. 28 No complication was noted with a dose of 75 g/kg IM in this study.
In conclusion, in injury groups, plasma Hcy levels decreased and PON1 activities increased as erythrocyte SOD levels and GSH-Px activities decreased in parallel to increases of tissue and blood MDA levels. These changes were relatively suppressed by PGE1, melatonin, and oxytetracycline administrations in varying degrees. Antioxidant enzymes are in collaboration with the PON1 enzyme, which keeps Hcy levels in physiologic ranges in the acute stage of the oxidative stress. Melatonin was most powerful agent, particularly at the fourth hour. Oxytetracycline was also effective, both at the first and fourth hours. PGE1 was effective in comparison to the injury group, but not as much as melatonin and oxytetracycline. PON1 and Hcy can be used in monitoring the antioxidant defense system as well as SOD and GSH-Px, both in injury and medicated groups.
Key Points
• Lipid peroxidation was monitored by tissue MDA level increase at the first and fourth hours the in rats by clip compression model of spinal cord injury.
• Activities of antioxidant SOD and GSPx enzymes (erythrocyte) were found reduced, whereas serum PON1 activity-an antioxidant enzymeincreased inversely correlated with the decrease of homocysteine levels. This inverse response was considered a protection response against the consumption of antioxidant enzymes valid for the acute stage.
• Melatonin was the most powerful agent in suppressing MDA levels and the antioxidant enzyme responses, and it can be useful in the treatment of spinal cord injury. PON1 and homocysteine can be used in monitoring the antioxidant responses in an acute oxidative stress.
